Validation pour Ingenuity294

vers la météo de la validation par utilisateur

Ingenuity294

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 0 - PMID ?

In primary SP keratinocytes , MG 132 increases expression of SP NODE protein that is decreased by cycloheximide .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A1">Analyse 1

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A2">Analyse 2

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A3">Analyse 3

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A4">Analyse 4

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A5">Analyse 5

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A6">Analyse 6

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A7">Analyse 7

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A8">Analyse 8

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A9">Analyse 9

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A10">Analyse 10

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A11">Analyse 11

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A12">Analyse 12

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A13">Analyse 13

                                                                             +---------OBJ:V-N--------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A14">Analyse 14

       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A15">Analyse 15

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A16">Analyse 16

                                                                     +-------------OBJ:V-N------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A17">Analyse 17

       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A18">Analyse 18

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A19">Analyse 19

                                                         +-------------------OBJ:V-N------------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A20">Analyse 20

       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A21">Analyse 21

                                                         +-------------------OBJ:V-N------------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A22">Analyse 22

                                                         +-------------------OBJ:V-N------------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A23">Analyse 23

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                              +---------OBJ:V-N--------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A24">Analyse 24

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A25">Analyse 25

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                      +-------------OBJ:V-N------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A26">Analyse 26

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A27">Analyse 27

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A28">Analyse 28

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A29">Analyse 29

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A30">Analyse 30

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A31">Analyse 31

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A32">Analyse 32

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A33">Analyse 33

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A34">Analyse 34

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A35">Analyse 35

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A36">Analyse 36

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A37">Analyse 37

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A38">Analyse 38

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A39">Analyse 39

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A40">Analyse 40

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |                   +---------OBJ:V-N--------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A41">Analyse 41

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A42">Analyse 42

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |           +-------------OBJ:V-N------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A43">Analyse 43

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A44">Analyse 44

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A45">Analyse 45

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A46">Analyse 46

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A47">Analyse 47

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A48">Analyse 48

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +---------------SUBJ:V-N---------------+     |                       
                                                         +--------COMP:N-N(of)-------+          |     |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A49">Analyse 49

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A50">Analyse 50

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +---------------SUBJ:V-N---------------+     |                       
                         |                               +--------COMP:N-N(of)-------+          |     |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+          |     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A51">Analyse 51

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A52">Analyse 52

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +---------------SUBJ:V-N---------------+     |              |        
                                              |          +--------COMP:N-N(of)-------+          |     |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A53">Analyse 53

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A54">Analyse 54

                                                                             +---------OBJ:V-N--------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A55">Analyse 55

       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A56">Analyse 56

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A57">Analyse 57

                                                                     +-------------OBJ:V-N------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A58">Analyse 58

       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A59">Analyse 59

                                                         +--------COMP:N-N(of)-------+----------COMP:N-N(by)---------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A60">Analyse 60

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A61">Analyse 61

                                                         +-------------------OBJ:V-N------------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A62">Analyse 62

       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A63">Analyse 63

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A64">Analyse 64

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A65">Analyse 65

                                                         +-------------------OBJ:V-N------------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A66">Analyse 66

                                                         +-------------------OBJ:V-N------------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A67">Analyse 67

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                              +---------OBJ:V-N--------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A68">Analyse 68

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A69">Analyse 69

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                      +-------------OBJ:V-N------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A70">Analyse 70

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A71">Analyse 71

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A72">Analyse 72

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A73">Analyse 73

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A74">Analyse 74

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A75">Analyse 75

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A76">Analyse 76

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A77">Analyse 77

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A78">Analyse 78

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +---------------SUBJ:V-N---------------+     |              |        
                                                         +--------COMP:N-N(of)-------+          |     |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A79">Analyse 79

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A80">Analyse 80

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A81">Analyse 81

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A82">Analyse 82

                                                                             +--------------COMP:N-N(by)-------------+        
                                                                             +---------OBJ:V-N--------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A83">Analyse 83

                                                                             +--------------COMP:N-N(by)-------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A84">Analyse 84

                                                                     +------------------COMP:N-N(by)-----------------+        
                                                                     +-------------OBJ:V-N------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A85">Analyse 85

                                                                     +------------------COMP:N-N(by)-----------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A86">Analyse 86

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A87">Analyse 87

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A88">Analyse 88

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |                   +---------OBJ:V-N--------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A89">Analyse 89

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A90">Analyse 90

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |           +-------------OBJ:V-N------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A91">Analyse 91

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A92">Analyse 92

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A93">Analyse 93

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A94">Analyse 94

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +---------------SUBJ:V-N---------------+     |                       
                                                         +--------COMP:N-N(of)-------+          |     |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A95">Analyse 95

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

name="reponse" value="A96">Analyse 96

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A97">Analyse 97

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A98">Analyse 98

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A99">Analyse 99

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A100">Analyse 100

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +---------------SUBJ:V-N---------------+     |                       
                         |                               +--------COMP:N-N(of)-------+          |     |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+          |     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A101">Analyse 101

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

name="reponse" value="A102">Analyse 102

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +---------------SUBJ:V-N---------------+     |              |        
                                              |          +--------COMP:N-N(of)-------+          |     |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A103">Analyse 103

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A104">Analyse 104

                                                         +--------COMP:N-N(of)-------+----------COMP:N-N(by)---------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A105">Analyse 105

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A106">Analyse 106

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A107">Analyse 107

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A108">Analyse 108

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +---------------SUBJ:V-N---------------+     |              |        
                                                         +--------COMP:N-N(of)-------+          |     |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A109">Analyse 109

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

name="reponse" value="A110">Analyse 110

                                                                             +--------------COMP:N-N(by)-------------+        
                                                                             +---------OBJ:V-N--------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A111">Analyse 111

                                                                             +--------------COMP:N-N(by)-------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A112">Analyse 112

                                                                     +------------------COMP:N-N(by)-----------------+        
                                                                     +-------------OBJ:V-N------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A113">Analyse 113

                                                                     +------------------COMP:N-N(by)-----------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A114">Analyse 114

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A115">Analyse 115

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A116">Analyse 116

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

name="reponse" value="A117">Analyse 117

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)